BB Biotech AG represents strong values and a solid corporate philosophy. As a leading biotech investment company, BB Biotech AG focuses on long-term capital appreciation through investments in the biotechnology industry. They strive to support innovative companies that develop cutting-edge therapies and healthcare solutions. This strategy aligns with their commitment to drive advancements and improvements in the healthcare sector. By investing in emerging biotech companies with significant growth potential, BB Biotech AG aims to generate sustainable returns for its shareholders.

BB Biotech AG is primarily present in Switzerland and Germany.

BB Biotech AG has achieved significant milestones in its history. Some notable achievements include the successful launch of its investment strategy focused on globally listed biotech companies. The company has also been able to deliver consistent returns to its shareholders, with a strong track record of portfolio performance. BB Biotech AG has established itself as a leader in the biotech sector, with a well-diversified portfolio of investments in innovative companies. The company has also been actively involved in supporting the development of breakthrough therapies and advancements in the biotech industry. Overall, BB Biotech AG's achievements reflect its commitment to supporting the growth and success of the biotech sector.

BB Biotech AG is a renowned Swiss investment company specializing in the healthcare sector. Established in 1993, BB Biotech has a rich history of success in generating long-term value for its shareholders. The company primarily focuses on investing in innovative biotech companies that exhibit strong growth potential. BB Biotech benefits from an experienced team of professionals dedicated to thoroughly assessing and selecting promising investment opportunities within the biotech industry. With its extensive expertise and broad network, BB Biotech seeks to capitalize on cutting-edge advancements in the healthcare sector. Throughout its history, BB Biotech has consistently delivered impressive returns for investors, solidifying its position as a leading player in the biotech investment space.

Some of the main competitors of BB Biotech AG in the market include Roche Holding AG, Novartis AG, and Johnson & Johnson.

BB Biotech AG is primarily active in the biotechnology industry.

BB Biotech AG is a biotechnology investment company headquartered in Switzerland. The company primarily focuses on investing in a portfolio of innovative and promising biotechnology companies, with a particular emphasis on companies developing and commercializing breakthrough therapies. BB Biotech AG aims to support and generate long-term value by investing in cutting-edge biotech companies that address unmet medical needs and have strong growth potential. By leveraging their extensive expertise and network within the biotech industry, BB Biotech AG aims to provide investors with an attractive investment opportunity in the rapidly evolving field of biotechnology.

مُعامل القيمة السوقية إلى الأرباح لـ BB Biotech هو ٩٫٧٧.

مُعامِل القيمة إلى المبيعات BB Biotech هو ١٦٫٢٠.

نقاط جودة AlleAktien لـ BB Biotech هي 2/10.

المتوقعة BB Biotech الإيرادات هي ١٢٦٫٩٩ مليون. CHF.

صافي الربح المتوقعة BB Biotech هو ٢١٠٫٤٩ مليون. CHF.

BB Biotech AG is a Swiss investment company specializing in biotechnology. The company actively invests worldwide in biotechnology companies working on innovative therapies to combat various diseases. Their approach focuses on companies developing medications and therapies based on genomic and protein research. The business model of BB Biotech AG is based on their position as strong and experienced investors in the biotechnology field. They invest in a variety of companies within their portfolio that focus on the development of innovative therapeutic options. The company strives for long-term success by investing in companies that utilize innovative technologies for drug manufacturing. BB Biotech AG is a key player in the global biotech market and a significant investor in this sector. In addition to their investment strategy, BB Biotech AG also offers comprehensive consulting services and expertise in the biotechnology and life sciences field. The company supports biotechnology companies in various stages of development, from research and development to drug approval and marketing. Their portfolio includes companies from various areas of biotechnology and life sciences, including biopharmaceuticals, diagnostics, medical technology, and genomics. Some of the key companies in their portfolio are Biotechnology Innovation Organization, Regeneron Pharmaceuticals, Gilead Sciences, Vertex Pharmaceuticals, and Blueprint Medicines. The company aims to actively manage and optimize their portfolio to provide investors with the highest benefit. Through careful research, analysis, and monitoring of biotechnology markets worldwide, BB Biotech AG is able to identify opportunities and act in a timely manner. Overall, BB Biotech AG offers an innovative business model based on a deep understanding of the biotechnology industry and a comprehensive portfolio of companies utilizing innovative technologies for drug manufacturing. The company provides comprehensive investment and consulting services and is a major player in the global biotech market.

يوزع BB Biotech أرباحًا قدرها 0 CHF من خلال 1 عمليات توزيع موزعة على مدار السنة.

BB Biotech يوزع أرباحًا 1 مرة في السنة.

الرمز الدولي للأوراق المالية الخاص بـBB Biotech هو CH0038389992.

رمز WKN لـ BB Biotech هو A0NFN3.

الرمز المُختصر لـ BB Biotech هو BION.SW.

خلال آخر 12 شهراً، دفعت BB Biotech توزيعات أرباح بقيمة . وهذا يعادل عائد توزيعات أرباح يقارب . ومن المتوقع أن تدفع BB Biotech خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ0 CHF.

نسبة توزيعات الأرباح الحالية لـ BB Biotech هي .

BB Biotech يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر .

BB Biotech دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة 0 CHF. وهذا يعادل عائد توزيعات أرباح قدره 0 %.

BB Biotech يُصنف ضمن قطاع '—'.

لكي تستلم آخر توزيعات أرباح بقيمة 0 CHF من BB Biotech المُعلن عنها في ٦‏/٩‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٦‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٦‏/٩‏/٢٠٢٤.

في العام 2023، وزعت BB Biotech 0 CHF كأرباح أسهم.

يتم توزيع أرباح BB Biotech بالعملة CHF.